ALPS Medical Breakthroughs ETF SBIO

Full chart Compare
Set alert

Price alert · SBIO

All alert types
54.37 USD +0.92 (+1.72%)

At closeNov 3, 2026, 4:00 PM EST

54.37 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

53.66 Day range 54.84
43.10 52-week range 70.85
YTD
+6.15%
1 year
+23.71%

ALPS Medical Breakthroughs ETF

Issuer
ALPS Funds
Asset class
Equity
Expense ratio
0.50%
Assets under management
$178.64M
NAV
53.33
Holdings
103
Inception
2014-12-30
Top 10 weight
31.76%

Top holdings

  1. ORKA Oruka Therapeutics Inc. 4.27%
  2. MANE VeraDermics Inc. 3.88%
  3. CGON CG oncology Inc. 3.82%
  4. DFTX Definium Therapeutics Inc. 3.25%
  5. TVTX Travere Therapeutics Inc. 3.16%
  6. DNTH Dianthus Therapeutics Inc. 3.07%
  7. EWTX Edgewise Therapeutics Inc. 2.81%
  8. RLAY Relay Therapeutics Inc. 2.68%
  9. AMLX Amylyx Pharmaceuticals Inc. 2.41%
  10. XENE Xenon Pharmaceuticals Inc. 2.41%
  11. ACAD ACADIA Pharmaceuticals Inc. 2.36%
  12. TARS Tarsus Pharmaceuticals Inc. 2.19%
  13. DYN Dyne Therapeutics Inc. 2.07%
  14. IRON Disc Medicine Inc. 2.07%
  15. IDYA Ideaya Biosciences Inc. 2.05%
  16. DNLI Denali Therapeutics Inc. 2.02%
  17. VRDN Viridian Therapeutics Inc. 1.86%
  18. MBX MBX Biosciences Inc. 1.79%
  19. ZLAB Zai Lab Ltd. 1.65%
  20. NAMS Newamsterdam Pharma Co. NV 1.60%
  21. CLDX Celldex Therapeutics Inc. 1.57%
  22. VERA Vera Therapeutics Inc. 1.49%
  23. XNCR Xencor Inc. 1.48%
  24. BCRX BioCryst Pharmaceuticals Inc. 1.44%
  25. LKFT Lakefront Biotherapeutics NV 1.43%

Sector weights

  • Healthcare 100.00%

Country weights

  • United States 91.87%
  • Canada 2.37%
  • United Kingdom 1.83%
  • China 1.73%
  • Netherlands 1.62%
  • Switzerland 0.33%
  • Belgium 0.25%

Updated 2026-11-03